Are TKIs favourable for the elderly with non-small-cell lung cancer?

BACKGROUND: Epidermal Growth Factor Receptor (EGFR) tyrosine-kinase inhibitors (TKIs) have changed treatment strategies for patients with advanced non-small-cell lung cancer (NSCLC) harbouring mutations in EGFR gene. This retrospective analysis assessed efficacy and safety of TKIs in elderly compare...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Oncotarget
Asıl Yazarlar: Rossi, Sabrina, D'Argento, Ettore, Schinzari, Giovanni, Dadduzio, Vincenzo, Di Noia, Vincenzo, Cassano, Alessandra, Barone, Carlo
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Impact Journals LLC 2016
Konular:
Research Paper: Gerotarget (Focus on Aging)
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC5216909/
https://ncbi.nlm.nih.gov/pubmed/27206674
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.9389
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller